The authors reply
Kidney Int
.
2019 Apr;95(4):992-993.
doi: 10.1016/j.kint.2018.12.010.
Authors
Brad H Rovin
1
,
Neil Solomons
2
,
Robert B Huizinga
2
Affiliations
1
Department of Internal Medicine-Nephrology, Ohio State University, Columbus, Ohio, USA. Electronic address: Brad.Rovin@osumc.edu.
2
Aurinia Pharmaceuticals Inc., Victoria Ringgold Standard Institution, Victoria, British Columbia, Canada.
PMID:
30904071
DOI:
10.1016/j.kint.2018.12.010
No abstract available
Publication types
Letter
Comment
MeSH terms
Cyclosporine
Double-Blind Method
Humans
Lupus Nephritis*
Substances
voclosporin
Cyclosporine